cmAngio® vs Merge PACS
AI Verdict
Choose cmAngio® if…
Choose cmAngio® if your primary objective is to enhance cardiovascular risk assessment in women by leveraging existing mammography data. This AI-powered solution specifically identifies Breast Arterial Calcifications (BAC) on both FFDM and DBT exams, providing crucial insights into cardiovascular health without additional radiation or procedures. It is ideal for integrating proactive cardiovascular screening into routine women's health imaging workflows.
View cmAngio® →Choose Merge PACS if…
Choose Merge PACS if your organization requires an enterprise-level imaging solution to streamline radiology workflows, consolidate multi-modality imaging data, and integrate AI insights across a multi-site health system. This robust PACS offers flexible deployment options (on-premise, cloud, hybrid) and provides a unified worklist for seamless access to third-party AI applications, optimizing diagnostic efficiency and comprehensive image management.
View Merge PACS →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | cmAngio® | Merge PACS |
|---|---|---|
| Pricing | Paid, out-of-pocket | Contact vendor |
| Deployment | Cloud-based, integrates with any DICOM-compliant viewer | On-premise, Cloud, Hybrid |
| FDA Status | Cleared AI-estimated | Yes AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
cmAngio®cmAngio offers a highly focused AI solution with quick installation (less than an hour) and direct integration into any DICOM-compliant viewer, providing a clear scorecard for its specific function. This makes it exceptionally user-friendly for its intended purpose, minimizing disruption to existing workflows. Merge PACS, while offering extensive customization and workflow enhancements, is a full PACS system with a broader scope, implying a more significant learning curve and integration effort.
Clinical Value
cmAngio®cmAngio provides direct, specific clinical value by leveraging FDA-cleared AI to detect Breast Arterial Calcifications (BAC) on existing mammograms, offering novel insights into cardiovascular health without additional procedures or radiation. While Merge PACS enhances overall diagnostic workflows and integrates AI, its primary value lies in optimizing imaging management rather than delivering a specific, new diagnostic insight itself.
Pricing & Value
cmAngio®Both tools require direct vendor contact for pricing, limiting transparency. However, cmAngio explicitly mentions potential 'limited-time offers for no-cost implementation and service,' suggesting more flexible or accessible entry points for adoption, especially for a specialized AI solution. Merge PACS, as an enterprise-level system, is likely a substantial capital investment.
Enterprise Readiness
Merge PACSMerge PACS is explicitly designed as an enterprise-level Picture Archiving and Communication System (PACS), offering comprehensive features for multi-site deployment, multi-modality support, and extensive integration with various healthcare IT systems (EMR/EHR, RIS, HIS, VNA). Its architecture is built for large-scale imaging management and AI orchestration, including on-premise, cloud, and hybrid deployment options. While cmAngio is HIPAA compliant and integrates into existing viewers, its scope is a specialized AI application rather than a full enterprise imaging platform.
Innovation
Merge PACSMerge PACS demonstrates significant innovation by providing a robust, cloud-ready platform that enables seamless integration and single worklist access to third-party AI applications, addressing a critical challenge in AI adoption across enterprises. While cmAngio offers an innovative specific AI diagnostic application (BAC detection for cardiovascular risk), Merge PACS's innovation lies in creating an ecosystem that facilitates the broader utilization and management of AI in radiology.
Support & Docs
Merge PACSMerge PACS, as an enterprise-level Picture Archiving and Communication System (PACS) from a major vendor, offers a significantly more extensive and publicly available suite of documentation, including data sheets, white papers, and DICOM conformance statements. This indicates a robust support infrastructure typical for complex enterprise solutions. CureMetrix cmAngio mentions an 'Operator's Manual' but does not demonstrate the same breadth of public resources.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | cmAngio® | Merge PACS |
|---|---|---|
| Product Name | cmAngiou00ae | Merge PACS |
| Company | CureMetrix | Merative |
| Primary Function | FDA-cleared AI software for detecting Breast Arterial Calcifications (BAC) on mammograms, providing insights into cardiovascular health and aiding early risk assessment. | Enterprise-level Picture Archiving and Communication System (PACS) that streamlines radiology workflows, consolidates imaging data, and integrates AI insights across multi-site health systems. |
| Key Functionality | AI-based detection of Breast Arterial Calcifications (BAC); Processes both Full-Field Digital Mammography (FFDM) and Digital Breast Tomosynthesis (DBT) exams; Provides visualization of BAC location on a scorecard. | AI integration and readiness (single worklist access to 3rd party AI applications); Customizable, composite worklist for multiple specialties; Enterprise-wide image management and consolidation. |
| Specialties Supported | Cardiology, Obstetrics & Gynecology, Radiology | Cardiology, Radiology |
Videos
Demos, reviews, and walkthroughs featuring cmAngio® and Merge PACS.